Clinical Trials
35 trialsCombination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer
National Cancer Institute (NCI)
Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
National Cancer Institute (NCI)
Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
National Cancer Institute (NCI)
SU006668 in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
National Cancer Institute (NCI)
Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
National Cancer Institute (NCI)
Brachytherapy in Treating Patients With Recurrent Prostate Cancer
National Cancer Institute (NCI)
Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
National Cancer Institute (NCI)
Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
National Cancer Institute (NCI)
Lycopene in Preventing Prostate Cancer in Healthy Participants
National Cancer Institute (NCI)
Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men
National Cancer Institute (NCI)
Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners
National Cancer Institute (NCI)
Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
National Cancer Institute (NCI)
Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
National Cancer Institute (NCI)
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
National Cancer Institute (NCI)
Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom
National Cancer Institute (NCI)
Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer
National Cancer Institute (NCI)
High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer
National Cancer Institute (NCI)
High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate Cancer
National Cancer Institute (NCI)
Study of Treatment Choice in Patients With Localized Prostate Cancer
National Cancer Institute (NCI)
Dutasteride in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer
National Cancer Institute (NCI)
Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer
National Cancer Institute (NCI)
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
National Cancer Institute (NCI)
Androgen Deprivation Therapy in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
MRI in Diagnosing Prostate Cancer
National Cancer Institute (NCI)
Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
National Cancer Institute (NCI)
DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer
National Cancer Institute (NCI)
A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA
National Center for Research Resources (NCRR)